查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1351069

2030 年药用玻璃包装市场预测：按细分市场和地区分類的全球分析

Pharmaceutical Glass Packaging Market Forecasts to 2030 - Global Analysis By Product (Vials, Bottles, Cartridges & Syringes and Ampoules), Drug Type (Generic, Branded and Biologic) and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球药用玻璃包装市场规模为 201 亿美元，预计预测期内年复合成长率为 11.4%，到 2030 年将达到 429 亿美元。

药用玻璃包装包括用于储存和保护药品的玻璃容器的生产和分销。这些玻璃包装透过提供无菌、不渗透的环境来保护药物的完整性、效力和稳定性，从而在整个保质期内保持药物的有效性。药用玻璃包装有多种形状，包括西林瓶、瓶子、安瓿和注射器，以适应各种药物类型和输送方法。

根据美国医疗保险和医疗补助服务中心的数据，美国全国医疗保健支出预计将以每年 5.4% 的速度成长，到 2028 年将达到 6.2 兆美元。

玻璃的商业价值随着可回收性的增加而增加

玻璃具有高度可回收性，其永续性与人们日益关注的环境问题不谋而合。玻璃可以无限回收，且不会降低质量，使其成为具有环保意识的消费者和行业的首选。随着永续性越来越受到关注，对用玻璃等可回收材料包装的产品的需求不断增长。这一趋势不仅推动了市场成长，也强调了采用环保包装解决方案的重要性，增加了玻璃包装在各个领域的吸引力和竞争力。

有限的创新

儘管塑胶等行业凭藉新的製造技术和智慧包装解决方案取得了迅速发展，但玻璃包装的进展却很缓慢。缺乏创新限制了玻璃有效满足现代市场需求的潜力。与技术适应性更强的材料相比，传统玻璃包装的智慧包装功能（例如追踪、防篡改和消费者互动）不太可行。此外，製药业需要专门的包装，例如受控药物控制释放系统，这可能会因玻璃缺乏多功能性而受到阻碍。

新兴国家製药业的成长

新兴国家不断增长的医疗保健需求和不断增长的中阶人口正在推动对药品和相应包装解决方案的需求。玻璃包装能够确保药品的完整性、稳定性和无菌性，并满足严格的药品品质要求。此外，对永续性和奢华包装的关注也增加了玻璃的吸引力。透过利用新兴国家快速成长的药品市场，玻璃包装製造商可以获得庞大的基本客群，并为药品的安全有效供应做出贡献。

替代材料的重要性日益增加

随着塑胶、纸张和其他材料的创新，工业界正在探索减轻重量、降低运输成本和提高生物分解性的方案。随着永续性越来越受到关注，人们认识到玻璃生产和运输对环境的影响，玻璃的地位可能会下降。製造商面临越来越大的压力，需要选择符合环保意识的消费者偏好的材料。在成本效率和环境友善等要素的推动下，向替代材料的转变可能会挑战玻璃在包装领域的传统主导地位，并影响其市场占有率和成长轨迹。

COVID-19 的影响：

儘管多个行业经历了供应链中断和原材料短缺，但 COVID-19 大流行对製药业影响甚微。製药公司对当地社区至关重要，因此不受关闭法规。一些包装业务也不受关闭限制，并正在从事医疗保健生产和支援。市场上的营运商正在透过自动化流程和分配尽可能少的人力资源来应对与 COVID-19 相关的药品包装需求的增加，以防止病毒传播。

预计瓶装市场在预测期内将是最大的市场

作为各种液体药品和固态剂型的主要容器，瓶子部分预计将出现良好的增长。其惰性和不可渗透的特性确保了药品的稳定性和完整性，对于维持产品功效至关重要。瓶子有多种尺寸，从用于精确剂量的小滴管瓶到用于批量剂量的大容器。这些瓶子具有防篡改密封和儿童用瓶盖等功能，以提高患者的安全。随着製药需求的发展和患者便利性变得越来越重要，瓶子在提供安全且易于使用的包装解决方案以满足製药行业严格的法规要求方面发挥着至关重要的作用。

预计仿製药部门在预测期内年复合成长率最高

预计仿製药领域在预测期内将以最快的年复合成长率成长。仿製药是一种在生物学上与品牌药物等效的非品牌药物。仿製药通常采用玻璃包装，提供了一种经济高效的替代，同时保持了药物的安全性和有效性。玻璃容器透过提供水分、氧气和光线的屏障来确保仿製药的稳定性并保持效力。此类包装解决方案有助于提高基本药物的可负担性和可近性。由于控制医疗成本的配合措施，对仿製药的需求持续增加，药用玻璃包装在为更​​多人带来高品质、价值主导的医疗保健解决方案方面发挥着至关重要的作用。

占比最高的地区

预计北美药用玻璃包装市场在预测期内将继续占据大部分市场占有率。该地区对患者安全、药品完整性和产品差异化的关注正在推动对高品质玻璃容器的需求。先进的製造能力和技术创新在北美产生了广泛的药用玻璃包装解决方案，包括西林瓶、瓶子和注射器。大型製药公司的存在和发达的医疗保健基础设施正在推动优质包装选择的采用。此外，该地区对永续包装的关注符合全球趋势，北美在塑造药用玻璃包装格局方面发挥关键作用。

复合年复合成长率最高的地区：

由于製药业的快速成长和医疗保健行业的扩张，预计亚太地区在预测期内将出现最高的年复合成长率。该地区对药品的需求不断增长，以及对产品安全和保质期的日益重视，推动了对高品质玻璃包装解决方案的需求。有利的法规情势和不断增加的可支配所得进一步推动了药用玻璃包装市场的发展。亚太地区的製造能力，加上主要企业的存在和创新技术，在供应各种玻璃容器、西林瓶和安瓿方面发挥着关键作用，这些玻璃容器、西林瓶和安瓿对于维持药品的完整性和有效性至关重要。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球药用玻璃包装市场：按产品

  • 小瓶
    • 小瓶
    • 大瓶
  • 瓶子
    • 小瓶
    • 大瓶
  • 药筒和注射器
  • 安瓿

第6章全球药用玻璃包装市场：依药品类型

  • 通用的
  • 品牌
  • 生物製剂

第7章全球药用玻璃包装市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第8章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第9章公司简介

  • Schott AG
  • Nipro Corporation
  • Owens-Illinois, Inc.
  • Arab Pharmaceutical Glass Co.
  • Sisecam Group
  • Stoelzle Oberglas GmbH
  • West Pharmaceutical Services, Inc.
  • Beatson Clark
  • Bormioli Pharma SpA
  • Corning Incorporated
  • Shandong Medicinal Glass Co., Ltd.
  • Ardagh Group SA
  • Piramal Enterprises Ltd.
  • Gerresheimer AG
Product Code: SMRC23756

According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $20.1 billion in 2023 and is expected to reach $42.9 billion by 2030 growing at a CAGR of 11.4% during the forecast period. The pharmaceutical glass packaging encompasses the production and distribution of glass containers designed to store and protects pharmaceutical products. These glass packaging solutions provide a sterile and impermeable environment that safeguards the integrity, potency, and stability of medications, ensuring they remain effective throughout their shelf life. Pharmaceutical glass packaging comes in various forms, such as vials, bottles, ampoules, and syringes, catering to diverse medication types and delivery methods.

According to the U.S. Centers for Medicare & Medicaid Services, the national health spending of the country is expected to grow at an annual rate of 5.4% and reach USD 6.2 trillion by 2028.

Market Dynamics:

Driver:

Commodity value of glass increased with recyclability

Glass is highly recyclable, and its sustainable nature aligns with increasing environmental concerns. The ability to be infinitely recycled without compromising quality makes glass a preferred choice for eco-conscious consumers and industries. As sustainability becomes a central focus, the demand for products packaged in recyclable materials, such as glass, has risen. This trend not only enhances the market's growth but also underscores the importance of adopting environmentally responsible packaging solutions, bolstering the attractiveness and competitiveness of glass packaging in various sectors.

Restraint:

Limited technological innovations

While industries like plastics have rapidly evolved with new manufacturing techniques and smart packaging solutions, glass packaging has experienced slower progress. This deficiency in innovation restricts the potential for glass to meet modern market demands effectively. Smart packaging features such as tracking, tamper-evidence, and interaction with consumers are less feasible in traditional glass packaging compared to more technologically adaptable materials. Moreover, the pharmaceutical industry's need for specialized packaging, such as controlled drug release systems, can be impeded by glass's relative lack of versatility.

Opportunity:

Growth of pharmaceutical industry in emerging economies

As these regions experience increasing healthcare needs and expanding middle-class populations, there is a higher demand for medicines and corresponding packaging solutions. Glass packaging's ability to ensure drug integrity, stability, and sterility aligns with the stringent quality requirements of pharmaceutical products. Moreover, the focus on sustainability and premium packaging enhances the appeal of glass. Capitalizing on the burgeoning pharmaceutical markets in emerging economies allows glass packaging manufacturers to tap into a significant customer base and contribute to the safe and effective delivery of medications.

Threat:

Increased relevance of alternate material

With innovations in plastics, paper, and other materials, industries are exploring options that offer lighter weight, reduced transportation costs, and improved biodegradability. As sustainability gains prominence, the perceived environmental impact of glass production and transportation might weaken its position. Manufacturers are increasingly pressured to choose materials that align with eco-conscious consumer preferences. This shift towards alternative materials, driven by factors such as cost efficiency and environmental considerations, challenges the traditional dominance of glass in packaging, potentially impacting its market share and growth trajectory.

COVID-19 Impact:

The COVID-19 pandemic experienced supply chain disruptions and a lack of raw materials in several industries, but it had little impact on the pharmaceutical sector. Pharmaceutical businesses were exempt from shutdown restrictions because they are vital to the community. A few of packaging businesses were also exempted from the lockdown limitations and were functioning to produce and support healthcare items. Businesses in the market are responding to the growing demand for packaging for pharmaceutical items connected to COVID-19 by automating their processes and allocating the fewest possible human resources in order to prevent the spread of the virus.

The bottles segment is expected to be the largest during the forecast period

The bottles segment is expected to have a lucrative growth serving as primary containers for various liquid medications and solid dosage forms. Their inert and impermeable properties ensure drug stability and integrity, vital for preserving product efficacy. Bottles come in a range of sizes, from small dropper bottles for precise dosing to larger containers for bulk medications. They offer features such as tamper-evident seals and child-resistant closures, enhancing patient safety. With evolving pharmaceutical needs and a growing focus on patient convenience, bottles play a pivotal role in providing secure and user-friendly packaging solutions that meet stringent regulatory requirements in the pharmaceutical industry.

The generic segment is expected to have the highest CAGR during the forecast period

The generic segment is anticipated to witness the fastest CAGR growth during the forecast period. Generic is non-branded medications that are bioequivalent to their branded counterparts. Generic pharmaceuticals often come in glass packaging, offering cost-effective alternatives while maintaining drug safety and efficacy. Glass containers ensure the stability of generic medicines by providing a barrier against moisture, oxygen, and light, preserving their potency. These packaging solutions contribute to the affordability and accessibility of essential medications. As the demand for generic drugs continues to rise due to healthcare cost containment efforts, pharmaceutical glass packaging plays a pivotal role in delivering high-quality, value-driven healthcare solutions to a broader population.

Region with largest share:

During the forecast period, it is expected that the North America Pharmaceutical Glass Packaging market will continue to hold a majority of the market share. The region's emphasis on patient safety, drug integrity, and product differentiation fuels the demand for high-quality glass containers. With advanced manufacturing capabilities and innovation, North America produces a wide array of pharmaceutical glass packaging solutions, including vials, bottles, and syringes. The presence of major pharmaceutical companies and a well-established healthcare infrastructure drives the adoption of premium packaging options. Additionally, the region's focus on sustainable packaging aligns with global trends, solidifying North America's significant role in shaping the pharmaceutical glass packaging landscape.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period due to its burgeoning pharmaceutical industry and expanding healthcare sector. The region's increasing demand for medicines, along with a growing focus on product safety and preservation, drives the need for high-quality glass packaging solutions. Favorable regulatory landscapes and rising disposable incomes further boost the pharmaceutical glass packaging market. Local manufacturing capabilities, coupled with the presence of key players and innovative technologies, contribute to Asia Pacific's significant role in supplying a wide range of glass containers, vials, and ampoules, essential for maintaining the integrity and efficacy of pharmaceutical products.

Key players in the market:

Some of the key players in Pharmaceutical Glass Packaging market include: Schott AG, Nipro Corporation, Owens-Illinois, Inc., Arab Pharmaceutical Glass Co., Sisecam Group,Stoelzle Oberglas GmbH, West Pharmaceutical Services, Inc., Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Shandong Medicinal Glass Co., Ltd., Ardagh Group S.A, Piramal Enterprises Ltd. and Gerresheimer AG.

Key Developments:

In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.

In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop new innovation and ideas about pharmaceutical packaging by focusing on augment reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.

In March 2023, Schott AG launched the production of FIOLAX®amber pharma glass in India with the aim to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

Products Covered:

  • Vials
  • Bottles
  • Cartridges & Syringes
  • Ampoules

Drug Types Covered:

  • Generic
  • Branded
  • Biologic

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Packaging Market, By Product

  • 5.1 Introduction
  • 5.2 Vials
    • 5.2.1 Small vials
    • 5.2.2 Large vials
  • 5.3 Bottles
    • 5.3.1 Small bottles
    • 5.3.2 Large bottles
  • 5.4 Cartridges & Syringes
  • 5.5 Ampoules

6 Global Pharmaceutical Glass Packaging Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Generic
  • 6.3 Branded
  • 6.4 Biologic

7 Global Pharmaceutical Glass Packaging Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Schott AG
  • 9.2 Nipro Corporation
  • 9.3 Owens-Illinois, Inc.
  • 9.4 Arab Pharmaceutical Glass Co.
  • 9.5 Sisecam Group
  • 9.6 Stoelzle Oberglas GmbH
  • 9.7 West Pharmaceutical Services, Inc.
  • 9.8 Beatson Clark
  • 9.9 Bormioli Pharma S.p.A.
  • 9.10 Corning Incorporated
  • 9.11 Shandong Medicinal Glass Co., Ltd.
  • 9.12 Ardagh Group S.A
  • 9.13 Piramal Enterprises Ltd.
  • 9.14 Gerresheimer AG

List of Tables

  • Table 1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 15 North America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 17 North America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 18 North America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 19 North America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 20 North America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 21 North America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 22 North America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 23 North America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 24 North America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 25 North America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 26 North America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 27 North America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 28 North America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 29 Europe Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 31 Europe Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 32 Europe Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 33 Europe Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 34 Europe Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 35 Europe Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 36 Europe Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 37 Europe Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 38 Europe Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 39 Europe Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 40 Europe Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 41 Europe Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 42 Europe Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 43 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 45 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 46 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 47 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 48 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 49 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 50 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 51 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 52 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 53 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 55 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 56 Asia Pacific Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 57 South America Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 59 South America Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 60 South America Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 61 South America Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 62 South America Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 63 South America Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 64 South America Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 65 South America Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 66 South America Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 67 South America Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 68 South America Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 69 South America Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 70 South America Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)
  • Table 71 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Product (2021-2030) ($MN)
  • Table 73 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Vials (2021-2030) ($MN)
  • Table 74 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small vials (2021-2030) ($MN)
  • Table 75 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large vials (2021-2030) ($MN)
  • Table 76 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 77 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Small bottles (2021-2030) ($MN)
  • Table 78 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Large bottles (2021-2030) ($MN)
  • Table 79 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Cartridges & Syringes (2021-2030) ($MN)
  • Table 80 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
  • Table 81 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 82 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Generic (2021-2030) ($MN)
  • Table 83 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Branded (2021-2030) ($MN)
  • Table 84 Middle East & Africa Pharmaceutical Glass Packaging Market Outlook, By Biologic (2021-2030) ($MN)